November 13, 2007

 

Press Release no.1

Market-wide Position Limit in OMAXE, POWERGRID & ADLABSFILM

 

The derivative contracts in the underlying OMAXE, POWERGRID & ADLABSFILM have crossed 95% of the market-wide position limit on November 13, 2007. It is hereby informed that all clients/ members shall trade in derivative contracts of  OMAXE, POWERGRID & ADLABSFILM by offsetting their existing positions till the open interest comes down to 80% of the market wide position limit.

 

 

Press Release no.2

News about Matrix Laboratories Limited

 

The media had reports that  Mylan may come out with a delisting offer for Matrix and are looking at buying the residual stake.

 

The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the officials of the company.

 

Matrix Laboratories Limited has vide its letter inter-alia stated,"As on date Mylan Laboratories Inc.,USA is neither contemplating to buy residual stake nor delist the securities of the Company from the Stock Exchanges. Hence, the news item is incorrect and baseless."

 

 

Press Release no.3

NSE completes its 1937th & 1938th Normal Settlements

 

The Exchange have successfully completed its 1937th & 1938th Normal Settlement (Rolling T+2 following SEBI directive) since inception i.e., Settlement Numbers N – 2007214 & 2007215 on November 13, 2007. The settlement statistics is as follows:

 

Particulars
Values
Values

 

N – 2007214

N- 2007215

Total traded quantity (lakhs)

5872.93

1766.52

Total traded value (Rs. In Crores)

16761.87

3171.18

Total value of the settlement (Securities) (Rs. In Crores)

4681.16

886.20

Total value of the settlement (Funds) (Rs. In Crores)

1555.02

506.99

Shortages for the settlement

0.36%

0.50%

% of  Delivery ( No. of shares deliverable / No. of shares traded )

22.43%

25.14%

 

Retail Debt Market have completed its 1211th & 1212th settlements details of which are as follows:

 

Settlement No.

Traded Value

Settlement Value

 

 

Securities

Funds

D- 2007214

NIL

NIL

NIL

D- 2007215

NIL

NIL

NIL